Igem Docking13
Igem Docking13
Practical no: 6
Aim: To perform Virtual Screening using iGEMDOCK.
Theory:
Methodology:
❖ Create Folders:
• Download the PDB complex for fluorouracil from the RCSB website.
• Note down the ligand number for fluorouracil.
• Place the downloaded file into the "receptor" folder.
❖ Use ChemSketch:
DY22SBBUOBID013
Pharmacoinformatics Date of Performance: 09-08-2024
❖ Create Derivatives:
❖ Save Compounds:
• Copy all six compounds (in PDF format) obtained from ArgusLab.
• Paste them into the "ligand" folder inside the "igm doc" folder.
• Go to the "igm doc" folder in the C drive, then open the "bin" option.
• A grey-colored dialog box will appear.
• Set the output path by clicking on the output path option.
• Navigate to the "VS_gauri" folder and select it.
• Go to the "prepare binding site" option and select the "Display" option on the right side.
• Choose the binding option and check if the small arrow-shaped drop-down shows "URF,"
which should match the ligand name from the PDB website.
• Click "Observe."
• In the command line window, enter background white and close the window.
• Return to the "prepare binding site" option.
• If the "Armstrong" option is checked, uncheck it.
• Click "Observe" again.
• In the command line, enter background purple or background white to change the
background color as desired.
• Close the window.
• Click "Start Docking." (Note: This will result in an error after a few minutes.)
❖ Analyze Interaction:
❖ Save Results:
• Save the analysis in an Excel file in the output folder and name it "T1.xls."
• To get the summary table, save all of the files in the folder as text files.
DY22SBBUOBID013
Pharmacoinformatics Date of Performance: 09-08-2024
Results:
DY22SBBUOBID013
Pharmacoinformatics Date of Performance: 09-08-2024
D1 D3 D5
Fig: Rasmol
DY22SBBUOBID013
Pharmacoinformatics Date of Performance: 09-08-2024
Fig : Chimera
DY22SBBUOBID013
Pharmacoinformatics Date of Performance: 09-08-2024
Interpretation:
Provides a detailed breakdown of the interactions between the ligand and the receptor,including the
fitness score as well as the interaction analysis with different amino acids.
DY22SBBUOBID013
Pharmacoinformatics Date of Performance: 09-08-2024
Conclusion:
Using the iGEMDOCK tool, a virtual screening of receptors, and 5 derivatives was performed.
After docking the proteins, post-docking screen analysis was performed. Here, compounds along
DY22SBBUOBID013